{"abstract": "Sanofi and Genzyme have agreed on the broad structure of a deal, and Sanofi is likely to raise the price it will pay for Genzyme shares from its current offer of $69.", "web_url": "https://dealbook.nytimes.com/2011/01/31/sanofi-and-genzyme-in-nondisclosure-pact/", "snippet": "Sanofi and Genzyme have agreed on the broad structure of a deal, and Sanofi is likely to raise the price it will pay for Genzyme shares from its current offer of $69.", "lead_paragraph": "8:32 p.m. | Updated ", "source": "The New York Times", "multimedia": [], "headline": {"main": "Sanofi and Genzyme Appear Close to a Deal", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Genzyme Corp", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Sanofi-Aventis S.A", "rank": 4, "major": "N"}], "pub_date": "2011-01-31T12:42:42+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Michael J. de la Merced", "person": [{"firstname": "Michael", "middlename": "J.", "lastname": "de la Merced", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/a1684d86-084f-57db-9286-f2e98f1771f7", "word_count": 492, "uri": "nyt://article/a1684d86-084f-57db-9286-f2e98f1771f7"}